FASN inhibitor 1
中文名称 | FASN inhibitor 1 |
---|---|
中文同义词 | 化合物FASN-IN-3;4-(1-(5-(3,4-二甲基-1H-吡唑-5-基0-2,4-二甲基苯甲酰基)氮杂环丁烷-3-基)苯甲腈;4-(1-(5-(3,4-二甲基-1H-吡唑-5-基)-2,4-二甲基苯甲酰基)氮杂环丁烷-3-基)苯甲腈 |
英文名称 | FASN inhibitor 1 |
英文同义词 | FASN inhibitor 1;FASN-IN-3;Benzonitrile, 4-[1-[5-(3,4-dimethyl-1H-pyrazol-5-yl)-2,4-dimethylbenzoyl]-3-azetidinyl]-;4-(1-(5-(3,4-Dimethyl-1H-pyrazol-5-yl)-2,4-dimethylbenzoyl)azetidin-3-yl)benzonitrile;Fatty Acid Synthase (FASN),Inhibitor,inhibit,FASNIN3,FASN IN 3 |
CAS号 | 2097262-60-5 |
分子式 | C24H24N4O |
分子量 | 384.47 |
EINECS号 | |
相关类别 | |
Mol文件 | 2097262-60-5.mol |
结构式 |
FASN inhibitor 1 性质
沸点 | 641.5±55.0 °C(Predicted) |
---|---|
密度 | 1.26±0.1 g/cm3(Predicted) |
形态 | 固体 |
酸度系数(pKa) | 14.66±0.50(Predicted) |
颜色 | 米白色至黄色 |
FASN
Human PBMC and monocytes in cell cultures are stimulated with lipopolysaccharide (LPS), a Toll 4 receptor agonist, or lipoteichoic acid (LTA), a Toll 2 receptor agonist. Stimulation with either LPS or LTA plus DMSO, the solvent for FASN-IN-3 (Compound 242A), results in secretion of IL-1 beta. FASN inhibitor 1 treatment of PBMC, which is a mixed population of mononuclear cells including both lymphocytes and monocytes, reduces the level of IL-1 beta resulting from either LPS or LTA stimulation. For monocytes, FASN-IN-3 treatment reduces the level of IL-1 beta resulting from LTA stimulation whereas there is only a slight reduction after LPS stimulation.
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/08/19 | HY-U00436 | FASN-IN-3 | 1 mg | 1200元 | |
2024/08/19 | HY-U00436 | FASN inhibitor 1 FASN-IN-3 | 2097262-60-5 | 5mg | 2800元 |